Skip to main content
About
About Us
Trustees
Our Team
Financials
Careers
Our Programs
Crohn’s Disease
Israel
Rural Healthcare
Type 1 Diabetes
Vulnerable Children in Sub-Saharan Africa
New York City
Our Grants
Grants Database
Grantee Resources
News & Insights
Latest News
Press Room
Latitude Pharmaceuticals, Inc.
Date of Award
12.03.2012
Program
Improve Outcomes
Amount
$694,220.00
Term of Grant
43 months
Project Title
Stabilized Glucagon Formulations